What is Evommune 's debt instrument face amount?

Evommune (EVMN) reported debt instrument face amount of $837.8K in Q1 2026.

What does debt instrument face amount mean?

The principal amount of debt obligations that the company is contractually required to repay at maturity. This metric is essential for assessing the company's total debt burden and its long-term financial obligations.

Evommune EVMN Debt Instrument Face Amount

Debt Instrument Face Amount at other companies

GTY

Getty RealtyGTY

$250M+203%

Flagstar Bank FLG

$212M0.0%

Essential Properties Realty TrustEPRT

$100M—

Stag IndustrialSTAG

$200M-60.9%

CenterspaceCSR

$150.43M+209%

ImaxIMAX

$46.7M-5.6%

Other financials

Income statement

See full

Revenue$1.6M+3.5%

Gross profit$961.1K+10.9%

Operating income-$682.8K-2,027%

Net income-$7.0M-5,414%

EPS (diluted)-$0.36-1,700%

Balance sheet

See full

Cash & equivalents$1.1M+401%

Total debt$2.0M—

Total equity-$4.5M-3,048%

Total assets$7.2M—

Cash flow

See full

Operating cash flow-$424.6K-341%

CapEx$1.0-99.8%

Free cash flow-$2.7M-4,996%

Valuation

See full

Market cap$848.59M+39.5%

Enterprise value$849.52M—

P/S127.3×—

Profitability

See full

Gross margin53.7%—

Operating margin-30.7%—

Net margin-90.1%—

Returns & leverage

See full

Return on equity275.7%—

Debt / equity1.4×—

Current ratio1.2×—

Where this comes from

Reported directly by Evommune in its filing.

Tagged under the XBRL concept us-gaap:DebtInstrumentFaceAmount.

The official record: Evommune ’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about Evommune 's debt instrument face amount.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Evommune 's debt instrument face amount?: Evommune (EVMN) reported debt instrument face amount of $837.8K in Q1 2026.
What does debt instrument face amount mean?: The principal amount of debt obligations that the company is contractually required to repay at maturity. This metric is essential for assessing the company's total debt burden and its long-term financial obligations.